Sensai
Reading the tape…Pulling live market data…Setting the scene…
Sensai
AI Stock Dissection
AI Stock Dissection
AKSHARCHEM
Ms. Paru Mrugesh Jaykrishna B.A., LL.B., M.A. · Ahmedabad, India
₹249.62
▲+1.11%AKSHARCHEM’s share price sits near the top of its 52‑week range amid a modest revenue up‑tick but persistent losses, hinting at short‑term upside potential if the turnaround narrative sustains.
Exchange
NSI
Currency
INR
Day range
₹235.30 – ₹251.70
52-week range
₹141.30 – ₹330.80
Sector
Basic Materials
Industry
Specialty Chemicals
AI investment rating
AI analysis60% confidence
At present, the stock trades near the upper third of its 52‑week band and is likely still undervalued relative to a medium‑term upside if earnings improve.
24.5% below the 1-year high · trend up
Hedge-fund memo
Today
Shares up 1.11%, trading within the day range 235.3–251.7, with modest intraday volume.
This week
Week‑to‑week movement negligible; price oscillates around 250 INR with no clear trend.
This month
Monthly trend flat; minor rally earlier in month but consolidated near 250 INR.
Bull thesis
Bear thesis
News & sentiment
Bearish
1 headlines · 1 outlets · 7d
MarketsMojo·2d ago·negative downgrade, weak fundamentals
Real press coverage from the last 7 days, scored by AI for tone — click any headline for the source. This is sentiment, not social: X / Reddit / Telegram scoring needs a paid social provider. Educational only.
Smart money
Named holders aren't published for this listing (common for Indian stocks). The split at left is live.
Financial health
Profitability
Growth
Balance sheet
Financial statements
Earnings intelligence
Beat estimates in 0 of 2 recent quarters (EPS actual vs. consensus).
12.36 vs 15.75
-21.52% surprise
9.82 vs 15.94
-38.39% surprise
Competitive landscape
| Company | Market cap | P/E | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| AKSHARCHEM | 2.01B | — | -0.17% | 1.01% | 16.60% |
| ASAHISONG | 4.43B | 12.71 | — | 14.37% | 26.00% |
| BHAGERIA | 8.82B | 12.77 | — |
Technical intelligence
Volume
RSI (14) · 70 overbought / 30 oversold
MACD (12,26,9) · MACD vs signal
Candlesticks, volume, RSI and MACD from 498sessions of real Yahoo daily data. Moving averages use full history, so they're accurate at the left edge. Support / resistance are the 52-week low / high. Educational — technical signals are not buy or sell calls.
Risk intelligence
Continued negative profitability
Mitigation: Monitor margin improvement and cost‑control initiatives.
High debt burden limiting growth
Mitigation: Track debt repayment schedule and interest coverage.
Regulatory compliance costs
Mitigation: Stay updated on industry regulations.
Business intelligence
Competitive moat
The company’s niche specialty products and modest scale offer limited competitive barriers; moat relies on product differentiation and cost efficiencies.
Supply chain
Upstream (inputs / suppliers)
↓
Downstream (customers / markets)
M&A / strategic moves
No notable recent activity flagged.
Catalyst calendar
EPS report and debt update
Potential impact on debt servicing costs
Thesis builder
Bull case
If AKSHARCHEM successfully restructures its cost base and delivers margin expansion, the stock could rally 15–25% in 12–18 months.
Base case
The stock trades near 250 INR, comfortably above its 52‑week low yet below the high, suggesting a modest upside within the current range.
Bear case
Persistent losses and high leverage could lead to further decline if the company fails to reverse its negative profitability trend.
Time horizon
12–18 months
Est. CAGR
Revenue CAGR 15–20% (if growth continues), EPS CAGR –5% to break even
Entry (qual.)
Entry at 250‑260 INR when price consolidates post‑earnings.
Exit (qual.)
Target 300‑320 INR if margin recovery and debt reduction materialize.
Knowledge graph
Executives & sector are live; peers are clickable → their dissection. Institutional holders shown where the exchange publishes them.
Portfolio impact
Enter tickers + weights, then see how AKSHARCHEM fits.
Scenario simulator
Simulate a macro shock and see the illustrative impact:
Tailwind for tech & enablers.
Illustrative impact
Medium prob.Directional illustration only — not modelled on this company's actuals. A real simulator needs company financials.
Explain like…
Re-explain AKSHARCHEM for a different audience:
Pick a persona to get a tailored explanation.
Sensai publishes educational market commentary, not investment advice. We are not SEBI-registered investment advisers or research analysts, and nothing here is a recommendation to buy, sell, or hold any security.
Live prices, index levels, and other market data are pulled from third-party feeds, may be delayed, and can be inaccurate or unavailable. Do not rely on them for trading decisions.
Investing in equities carries risk, including the loss of principal. Always do your own research and consider consulting a SEBI-registered adviser before making any investment decision.
Hidden risks
Hidden opportunities
Watch next
Maintain a cautious hold; monitor earnings turnaround and debt metrics.
Annual income statement, oldest → newest. Live via Yahoo.
| 11.31% |
| 81.90% |
| BODALCHEM | 8.79B | 18.37 | 4.23% | 9.18% | 30.40% |
Peers via Yahoo's similarity graph, same-sector first; fundamentals live. Ask the AI copilot below for a qualitative head-to-head.
Support (day/52w low)
₹235.30
Resistance (day/52w high)
₹251.70
Volume
5,586
Trend
up
RSI (14)
66
MACD
bullish
MA cross
golden
50-day MA
₹224.99
200-day MA
₹222.89
vs 200-DMA
12.0%
RSI/MACD computed from 6 months of daily closes; moving averages from Yahoo. Options positioning still needs an options feed.
Overall conviction 60%